Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $30,933 - $34,418
-148 Reduced 0.65%
22,518 $4.92 Million
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $7,314 - $8,409
-37 Reduced 0.16%
22,666 $5.15 Million
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $7,438 - $8,202
-37 Reduced 0.16%
22,703 $4.56 Million
Q2 2023

Aug 21, 2023

BUY
$211.93 - $241.33 $32,637 - $37,164
154 Added 0.68%
22,740 $5.49 Million
Q1 2023

May 11, 2023

SELL
$213.32 - $257.83 $4.41 Million - $5.33 Million
-20,654 Reduced 47.77%
22,586 $5.18 Million
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $599,955 - $733,216
-2,945 Reduced 6.38%
43,240 $10.2 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $273,830 - $350,548
-1,337 Reduced 2.81%
46,185 $9.46 Million
Q2 2022

Aug 11, 2022

BUY
$213.86 - $277.87 $115,270 - $149,771
539 Added 1.15%
47,522 $11.1 Million
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $1.06 Million - $1.22 Million
4,086 Added 9.53%
46,983 $12.4 Million
Q4 2021

Mar 11, 2022

BUY
$271.6 - $314.21 $4.05 Million - $4.69 Million
14,912 Added 53.29%
42,897 $13.5 Million
Q3 2021

Nov 10, 2021

BUY
$274.82 - $308.34 $6.81 Million - $7.64 Million
24,766 Added 769.37%
27,985 $7.88 Million
Q1 2021

Apr 21, 2021

BUY
$204.88 - $255.03 $130,098 - $161,944
635 Added 24.57%
3,219 $821,000
Q4 2020

Feb 12, 2021

SELL
$186.91 - $214.42 $25,793 - $29,589
-138 Reduced 5.07%
2,584 $526,000
Q3 2020

Oct 30, 2020

SELL
$167.03 - $201.3 $31,067 - $37,441
-186 Reduced 6.4%
2,722 $512,000
Q2 2020

Aug 12, 2020

SELL
$113.31 - $182.44 $28,214 - $45,427
-249 Reduced 7.89%
2,908 $483,000
Q1 2020

May 13, 2020

BUY
$104.32 - $195.28 $145,526 - $272,415
1,395 Added 79.17%
3,157 $399,000
Q4 2019

Feb 12, 2020

SELL
$163.48 - $173.61 $8,010 - $8,506
-49 Reduced 2.71%
1,762 $299,000
Q3 2019

Nov 13, 2019

SELL
$159.77 - $178.1 $520,690 - $580,427
-3,259 Reduced 64.28%
1,811 $304,000
Q2 2019

Aug 14, 2019

BUY
$144.16 - $172.9 $491,441 - $589,416
3,409 Added 205.24%
5,070 $876,000
Q1 2019

May 15, 2019

BUY
$123.7 - $156.3 $205,465 - $259,614
1,661 New
1,661 $255,000
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $221,463 - $319,106
-1,833 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $4,024 - $4,518
24 Added 1.33%
1,833 $319,000
Q2 2018

Aug 13, 2018

SELL
$160.33 - $189.41 $324,347 - $383,176
-2,023 Reduced 52.79%
1,809 $324,000
Q1 2018

May 14, 2018

SELL
$161.53 - $178.11 $5,330 - $5,877
-33 Reduced 0.85%
3,832 $620,000
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $3,107 - $3,442
21 Added 0.55%
3,865 $616,000
Q3 2017

Nov 14, 2017

SELL
$149.47 - $160.56 $292,662 - $314,376
-1,958 Reduced 33.75%
3,844 $581,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,802
5,802 $895,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.